ID

31639

Beschreibung

Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers; ODM derived from: https://clinicaltrials.gov/show/NCT00984919

Link

https://clinicaltrials.gov/show/NCT00984919

Stichworte

Versionen (1)
  1. 15.09.18 15.09.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

15. September 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT00984919

Englisch

Eligibility Prostate Cancer NCT00984919

1 Formulare  
Criteria
Beschreibung

Criteria

meets one of the following criteria:
Beschreibung

Criteria Quantity Fulfill

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C1550543
histopathologically confirmed prostate cancer meeting 1 of the following criteria:
Beschreibung

Prostate carcinoma | Criteria Quantity Fulfill

Datentyp

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2,1]
C0243161
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C1550543
newly diagnosed untreated disease
Beschreibung

Disease untreated

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0332155
received prior local therapy (prostatectomy, definitive radiotherapy, brachytherapy, or cryotherapy) with no evidence of disease activity (defined as serum psa < 0.4 ng/ml post therapy) and by imaging studies
Beschreibung

Local Therapy | Prostatectomy | Therapeutic radiology procedure Definitive | Brachytherapy | Cold Therapy | Disease remission Imaging studies | Prostate specific antigen measurement Post Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C1517925
UMLS CUI [2]
C0033573
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0443196
UMLS CUI [4]
C0006098
UMLS CUI [5]
C0010412
UMLS CUI [6,1]
C0544452
UMLS CUI [6,2]
C1881134
UMLS CUI [7,1]
C0201544
UMLS CUI [7,2]
C0687676
UMLS CUI [7,3]
C0087111
experienced biochemical failure (defined as rise in serum psa ≥ 0.4 ng/ml post therapy)
Beschreibung

Therapeutic procedure Biochemical failed | Raised prostate specific antigen Post Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0205474
UMLS CUI [1,3]
C0231175
UMLS CUI [2,1]
C0178415
UMLS CUI [2,2]
C0687676
UMLS CUI [2,3]
C0087111
healthy volunteer (clinic patient with no history of clinically significant malignancies within the past 6 months)
Beschreibung

Healthy Volunteer | Malignant Neoplasms Absent

Datentyp

boolean

Alias
UMLS CUI [1]
C1708335
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0332197
patient characteristics:
Beschreibung

Client Characteristics

Datentyp

boolean

Alias
UMLS CUI [1]
C0815172
no clinical evidence of liver cirrhosis or chronic liver disease (i.e., evidence of ascites or severe coagulopathy)
Beschreibung

Liver Cirrhosis Absent | Chronic liver disease Absent | Ascites | Blood Coagulation Disorder Severe

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023890
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0341439
UMLS CUI [2,2]
C0332197
UMLS CUI [3]
C0003962
UMLS CUI [4,1]
C0005779
UMLS CUI [4,2]
C0205082
no active prostatitis
Beschreibung

Prostatitis Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0033581
UMLS CUI [1,2]
C0332197
prior concurrent therapy:
Beschreibung

Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Beschreibung

ID.11

Datentyp

boolean

more than 30 days since prior and no concurrent regular antiplatelet agents (including aspirin, anagrelide, cilastazole, clopidogrel, dipyridamole, pentoxiphylline, sulfinpyrazone, or ticlopidine)
Beschreibung

Antiplatelet Agents Absent | Aspirin Absent | Anagrelide Absent | Cilostazol Absent | Clopidogrel Absent | Dipyridamole Absent | Pentoxifylline Absent | Sulfinpyrazone Absent | Ticlopidine Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0085826
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0004057
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0051809
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0055729
UMLS CUI [4,2]
C0332197
UMLS CUI [5,1]
C0070166
UMLS CUI [5,2]
C0332197
UMLS CUI [6,1]
C0012582
UMLS CUI [6,2]
C0332197
UMLS CUI [7,1]
C0030899
UMLS CUI [7,2]
C0332197
UMLS CUI [8,1]
C0038742
UMLS CUI [8,2]
C0332197
UMLS CUI [9,1]
C0040207
UMLS CUI [9,2]
C0332197
more than 7 days since prior and no concurrent nsaids (including ibuprofen, celecoxib, diclofenac, diflunisal, etodolac, fenoprofen, flurbiprofen, indomethacin, ketoprofen, meclofenamate, mefenamic acid, nabumetone, naproxen, oxaprozin, piroxicam, sulindac, or tolmetin)
Beschreibung

NSAIDs Absent | Ibuprofen Absent | Celecoxib Absent | Diclofenac Absent | Diflunisal Absent | Etodolac Absent | Fenoprofen Absent | Flurbiprofen Absent | Indomethacin Absent | Ketoprofen Absent | Meclofenamate Absent | Mefenamic Acid Absent | Nabumetone Absent | Naproxen Absent | Oxaprozin Absent | Piroxicam Absent | Sulindac Absent | Tolmetin Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003211
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0020740
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0538927
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0012091
UMLS CUI [4,2]
C0332197
UMLS CUI [5,1]
C0012228
UMLS CUI [5,2]
C0332197
UMLS CUI [6,1]
C0059865
UMLS CUI [6,2]
C0332197
UMLS CUI [7,1]
C0015837
UMLS CUI [7,2]
C0332197
UMLS CUI [8,1]
C0016377
UMLS CUI [8,2]
C0332197
UMLS CUI [9,1]
C0021246
UMLS CUI [9,2]
C0332197
UMLS CUI [10,1]
C0022635
UMLS CUI [10,2]
C0332197
UMLS CUI [11,1]
C1289957
UMLS CUI [11,2]
C0332197
UMLS CUI [12,1]
C0025152
UMLS CUI [12,2]
C0332197
UMLS CUI [13,1]
C0068334
UMLS CUI [13,2]
C0332197
UMLS CUI [14,1]
C0027396
UMLS CUI [14,2]
C0332197
UMLS CUI [15,1]
C0069739
UMLS CUI [15,2]
C0332197
UMLS CUI [16,1]
C0031990
UMLS CUI [16,2]
C0332197
UMLS CUI [17,1]
C0038792
UMLS CUI [17,2]
C0332197
UMLS CUI [18,1]
C0040377
UMLS CUI [18,2]
C0332197
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Prostate Cancer NCT00984919

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Criteria Quantity Fulfill
Item
meets one of the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Prostate carcinoma | Criteria Quantity Fulfill
Item
histopathologically confirmed prostate cancer meeting 1 of the following criteria:
boolean
C0600139 (UMLS CUI [1])
C0243161 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1550543 (UMLS CUI [2,3])
Disease untreated
Item
newly diagnosed untreated disease
boolean
C0012634 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Local Therapy | Prostatectomy | Therapeutic radiology procedure Definitive | Brachytherapy | Cold Therapy | Disease remission Imaging studies | Prostate specific antigen measurement Post Therapeutic procedure
Item
received prior local therapy (prostatectomy, definitive radiotherapy, brachytherapy, or cryotherapy) with no evidence of disease activity (defined as serum psa < 0.4 ng/ml post therapy) and by imaging studies
boolean
C1517925 (UMLS CUI [1])
C0033573 (UMLS CUI [2])
C1522449 (UMLS CUI [3,1])
C0443196 (UMLS CUI [3,2])
C0006098 (UMLS CUI [4])
C0010412 (UMLS CUI [5])
C0544452 (UMLS CUI [6,1])
C1881134 (UMLS CUI [6,2])
C0201544 (UMLS CUI [7,1])
C0687676 (UMLS CUI [7,2])
C0087111 (UMLS CUI [7,3])
Therapeutic procedure Biochemical failed | Raised prostate specific antigen Post Therapeutic procedure
Item
experienced biochemical failure (defined as rise in serum psa ≥ 0.4 ng/ml post therapy)
boolean
C0087111 (UMLS CUI [1,1])
C0205474 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0178415 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
Healthy Volunteer | Malignant Neoplasms Absent
Item
healthy volunteer (clinic patient with no history of clinically significant malignancies within the past 6 months)
boolean
C1708335 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Liver Cirrhosis Absent | Chronic liver disease Absent | Ascites | Blood Coagulation Disorder Severe
Item
no clinical evidence of liver cirrhosis or chronic liver disease (i.e., evidence of ascites or severe coagulopathy)
boolean
C0023890 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0341439 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0003962 (UMLS CUI [3])
C0005779 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
Prostatitis Absent
Item
no active prostatitis
boolean
C0033581 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.11
Item
see disease characteristics
boolean
Antiplatelet Agents Absent | Aspirin Absent | Anagrelide Absent | Cilostazol Absent | Clopidogrel Absent | Dipyridamole Absent | Pentoxifylline Absent | Sulfinpyrazone Absent | Ticlopidine Absent
Item
more than 30 days since prior and no concurrent regular antiplatelet agents (including aspirin, anagrelide, cilastazole, clopidogrel, dipyridamole, pentoxiphylline, sulfinpyrazone, or ticlopidine)
boolean
C0085826 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0004057 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0051809 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0055729 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0070166 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0012582 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
C0030899 (UMLS CUI [7,1])
C0332197 (UMLS CUI [7,2])
C0038742 (UMLS CUI [8,1])
C0332197 (UMLS CUI [8,2])
C0040207 (UMLS CUI [9,1])
C0332197 (UMLS CUI [9,2])
NSAIDs Absent | Ibuprofen Absent | Celecoxib Absent | Diclofenac Absent | Diflunisal Absent | Etodolac Absent | Fenoprofen Absent | Flurbiprofen Absent | Indomethacin Absent | Ketoprofen Absent | Meclofenamate Absent | Mefenamic Acid Absent | Nabumetone Absent | Naproxen Absent | Oxaprozin Absent | Piroxicam Absent | Sulindac Absent | Tolmetin Absent
Item
more than 7 days since prior and no concurrent nsaids (including ibuprofen, celecoxib, diclofenac, diflunisal, etodolac, fenoprofen, flurbiprofen, indomethacin, ketoprofen, meclofenamate, mefenamic acid, nabumetone, naproxen, oxaprozin, piroxicam, sulindac, or tolmetin)
boolean
C0003211 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0020740 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0538927 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0012091 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0012228 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0059865 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
C0015837 (UMLS CUI [7,1])
C0332197 (UMLS CUI [7,2])
C0016377 (UMLS CUI [8,1])
C0332197 (UMLS CUI [8,2])
C0021246 (UMLS CUI [9,1])
C0332197 (UMLS CUI [9,2])
C0022635 (UMLS CUI [10,1])
C0332197 (UMLS CUI [10,2])
C1289957 (UMLS CUI [11,1])
C0332197 (UMLS CUI [11,2])
C0025152 (UMLS CUI [12,1])
C0332197 (UMLS CUI [12,2])
C0068334 (UMLS CUI [13,1])
C0332197 (UMLS CUI [13,2])
C0027396 (UMLS CUI [14,1])
C0332197 (UMLS CUI [14,2])
C0069739 (UMLS CUI [15,1])
C0332197 (UMLS CUI [15,2])
C0031990 (UMLS CUI [16,1])
C0332197 (UMLS CUI [16,2])
C0038792 (UMLS CUI [17,1])
C0332197 (UMLS CUI [17,2])
C0040377 (UMLS CUI [18,1])
C0332197 (UMLS CUI [18,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video